*Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A.

†Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, U.S.A.

Accepted for publication August 8, 2023.

Supported by the Research to Prevent Blindness, New York, NY, USA—Unrestricted Grant to Department of Ophthalmology, Vanderbilt University Medical Center.

L.A.M. is an advisor/consultant for Horizon Therapeutics. The other author has no financial or conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.op-rs.com).

The processes followed in this study were consistent with the ethical standards of the Helsinki Declaration (1964, amended in 1975, 1983, 1989, 1996, and 2000) of the World Medical Association. Informed consent was not required, as the review did not include patient-level data.

Address correspondence and reprint requests to Louise A. Mawn, MD, Vanderbilt Eye Institute, Vanderbilt University Medical Center, 2311 Pierce Avenue, Nashville, TN 37232-8808. E-mail: [email protected]